Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Capstone Therapeutics Corp. (CAPS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11
   10-K10-K10-K10-K/A10-K10-K10-K10-K
Revenues  2.00.00.00.00.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  2.00.00.00.00.00.00.00.0
            Gross margin  100.0%       
Selling, general and administrative   [+]0.60.60.51.81.51.21.83.5
Research and development  1.41.01.01.23.13.12.46.4
Other operating expenses  0.3 -3.3-5.9-9.1-8.6-8.3-19.8
EBITDA   [+]   3.14.84.54.210.0
            EBITDA margin  -1.2%       
Depreciation     0.20.20.20.00.1
EBITA  0.0-1.51.93.04.64.34.19.9
            EBITA margin  -1.2%       
Amortization of intangibles  0.20.20.2     
EBIT   [+]-0.2-1.71.73.04.64.34.19.9
            EBIT margin  -9.1%       
Interest expense, net   [+]        
Other income (expense), net  -0.3-0.1-0.10.00.0-0.2-0.10.0
Pre-tax income  -0.4-1.81.73.04.64.14.19.9
Income taxes  -0.10.00.10.20.40.00.00.2
            Tax rate  12.0%2.0%3.4%6.5%8.8%0.5%0.0%1.6%
Minority interest    0.9  0.20.5 
Net income  -0.4-1.80.72.84.23.93.69.7
            Net margin  -19.0%       
   
Basic EPS   [+]($6.99)($37.20)$0.02$0.07$0.10$0.10$0.09$0.24
Diluted EPS   [+]($6.99)($37.20)$0.02$0.07$0.10$0.10$0.09$0.24
   
Shares outstanding (basic)   [+]0.10.040.940.940.940.940.940.8
Shares outstanding (diluted)   [+]0.10.040.940.940.940.940.940.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy